An Observational Study on Medullary Thyroid Cancer Clinical Trials
This observational study is looking at the experiences of people with medullary thyroid cancer (MTC) who consider or join clinical trials. It's not testing a new drug, but rather observing how many MTC patients decide to join a clinical trial and how many stay in the trial until it's finished. The goal is to better understand what patients experience in these studies to help improve future research. You can join if you have a confirmed diagnosis of medullary thyroid cancer, are 18 or older, and can give your informed consent. This study aims to enroll about 500 participants.
- Study design
- This is an observational study, meaning researchers will watch and collect information without giving any specific treatments. It aims to include about 500 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure how many patients remain in a clinical trial until completion at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of medullary thyroid cancer patients who decide to enroll in a clinical trial3 months
- Rate of medullary thyroid cancer patients who remain in clinical trial to trial completion12 months